Agios Pharmaceuticals Inc (AGIO)
EBITDA
-$416.80M
TTM · Period ending: · USD
AGIO EBITDA
Latest reported-$416.80Mperiod ending
Latest reported-$416.80Mperiod ending
AGIO TTM EBITDA (-$21.82M → -$416.80M)
TTM EBITDA
High-resolution chart · PNG
AGIO ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -416,798,000 | |
| -418,357,000 | |
| -408,620,000 | |
| -404,863,000 | |
| 699,576,000 | |
| 715,812,000 | |
| 723,622,000 | |
| 733,117,000 | |
| -358,964,000 | |
| -346,438,000 | |
| -345,465,000 | |
| -212,588,000 | |
| -202,653,000 | |
| -210,169,000 | |
| -223,237,000 | |
| -357,959,000 | |
| -360,243,000 | |
| -351,076,000 | |
| -347,178,000 | |
| -339,762,000 | |
| -344,609,000 | |
| -350,275,000 | |
| -299,659,000 | |
| -314,659,000 | |
| -331,853,000 | |
| -353,673,000 | |
| -411,369,000 | |
| -401,848,000 | |
| -395,122,000 | |
| -358,498,000 | |
| -355,307,000 | |
| -349,338,000 | |
| -329,376,000 | |
| -341,193,000 | |
| -314,362,000 | |
| -281,573,000 | |
| -266,246,000 | |
| -238,385,000 | |
| -195,277,000 | |
| -179,343,000 | |
| -156,695,000 | |
| -132,882,000 | |
| -115,359,000 | |
| -101,971,000 | |
| -58,989,000 | |
| -45,639,000 | |
| -52,766,000 | |
| -38,303,000 | |
| -52,549,000 | |
| -42,698,000 | |
| -37,443,000 | |
| -31,715,000 | |
| -25,814,000 | |
| -23,512,000 | |
| -21,815,000 |